|
|
||||||||

*
Beirne Carter Center for Immunology Research and
Department of Pathology, University of Virginia, Charlottesville, VA 22908
Hepatitis C virus (HCV) is a major human pathogen causing mild to
severe liver disease worldwide. This positive strand RNA virus is
remarkably efficient at establishing chronic infections. Although a
high rate of genetic variability may facilitate viral escape and
persistence in the face of Ag-specific immune responses, HCV may also
encode proteins that facilitate evasion of immunological surveillance.
To address the latter possibility, we examined the influence of
specific HCV gene products on the host immune response to vaccinia
virus in a murine model. Various vaccinia/HCV recombinants expressing
different regions of the HCV polyprotein were used for i.p. inoculation
of BALB/c mice. Surprisingly, a recombinant expressing the N-terminal
half of the polyprotein (including the structural proteins, p7, NS2,
and a portion of NS3; vHCV-S) led to a dose-dependent increase in
mortality. Increased mortality was not observed for a recombinant
expressing the majority of the nonstructural region or for a negative
control virus expressing the ß-galactosidase protein. Examination of
T cell responses in these mice revealed a marked suppression of
vaccinia-specific CTL responses and a depressed production of IFN-
and IL-2. By using a series of vaccinia/HCV recombinants, we found that
the HCV core protein was sufficient for immunosuppression, prolonged
viremia, and increased mortality. These results suggest that the HCV
core protein plays an important role in the establishment and
maintenance of HCV infection by suppressing host immune responses, in
particular the generation of virus-specific CTLs.
This article has been cited by other articles:
![]() |
P. Jagannathan, C. M. Osborne, C. Royce, M. M. Manion, J. C. Tilton, L. Li, S. Fischer, C. W. Hallahan, J. A. Metcalf, M. McLaughlin, et al. Comparisons of CD8+ T Cells Specific for Human Immunodeficiency Virus, Hepatitis C Virus, and Cytomegalovirus Reveal Differences in Frequency, Immunodominance, Phenotype, and Interleukin-2 Responsiveness J. Virol., March 15, 2009; 83(6): 2728 - 2742. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Lukens, M. W. Cruise, M. G. Lassen, and Y. S. Hahn Blockade of PD-1/B7-H1 Interaction Restores Effector CD8+ T Cell Responses in a Hepatitis C Virus Core Murine Model J. Immunol., April 1, 2008; 180(7): 4875 - 4884. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dominguez-Villar, A. Munoz-Suano, B. Anaya-Baz, S. Aguilar, J. P. Novalbos, J. A. Giron, M. Rodriguez-Iglesias, and F. Garcia-Cozar Hepatitis C virus core protein up-regulates anergy-related genes and a new set of genes, which affects T cell homeostasis J. Leukoc. Biol., November 1, 2007; 82(5): 1301 - 1310. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Ciccaglione, E. Stellacci, C. Marcantonio, V. Muto, M. Equestre, G. Marsili, M. Rapicetta, and A. Battistini Repression of Interferon Regulatory Factor 1 by Hepatitis C Virus Core Protein Results in Inhibition of Antiviral and Immunomodulatory Genes J. Virol., January 1, 2007; 81(1): 202 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Budhu and X. W. Wang The role of cytokines in hepatocellular carcinoma J. Leukoc. Biol., December 1, 2006; 80(6): 1197 - 1213. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Saito, K. Meyer, R. Warner, A. Basu, R. B. Ray, and R. Ray Hepatitis C Virus Core Protein Inhibits Tumor Necrosis Factor Alpha-Mediated Apoptosis by a Protective Effect Involving Cellular FLICE Inhibitory Protein J. Virol., May 1, 2006; 80(9): 4372 - 4379. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Li, J. Li, D. L. J. Tyrrell, and B. Agrawal Expression of hepatitis C virus-derived core or NS3 antigens in human dendritic cells leads to induction of pro-inflammatory cytokines and normal T-cell stimulation capabilities J. Gen. Virol., January 1, 2006; 87(1): 61 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Q. Yao, S. N. Waggoner, M. W. Cruise, C. Hall, X. Xie, D. W. Oldach, and Y. S. Hahn SOCS1 and SOCS3 Are Targeted by Hepatitis C Virus Core/gC1qR Ligation To Inhibit T-Cell Function J. Virol., December 15, 2005; 79(24): 15417 - 15429. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Waggoner, M. W. Cruise, R. Kassel, and Y. S. Hahn gC1q Receptor Ligation Selectively Down-Regulates Human IL-12 Production through Activation of the Phosphoinositide 3-Kinase Pathway J. Immunol., October 1, 2005; 175(7): 4706 - 4714. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Cruise, H. M. Melief, J. Lukens, C. Soguero, and Y. S. Hahn Increased Fas ligand expression of CD4+ T cells by HCV core induces T cell-dependent hepatic inflammation J. Leukoc. Biol., August 1, 2005; 78(2): 412 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Joo, Y. S. Hahn, M. Kwon, R. T. Sadikot, T. S. Blackwell, and J. W. Christman Hepatitis C Virus Core Protein Suppresses NF-{kappa}B Activation and Cyclooxygenase-2 Expression by Direct Interaction with I{kappa}B Kinase {beta} J. Virol., June 15, 2005; 79(12): 7648 - 7657. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Boni, J.-P. Lavergne, S. Boulant, and A. Cahour Hepatitis C Virus Core Protein Acts as a trans-Modulating Factor on Internal Translation Initiation of the Viral RNA J. Biol. Chem., May 6, 2005; 280(18): 17737 - 17748. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sundstrom, S. Ota, L. Y. Dimberg, M. G. Masucci, and A. Bergqvist Hepatitis C Virus Core Protein Induces an Anergic State Characterized by Decreased Interleukin-2 Production and Perturbation of Mitogen-Activated Protein Kinase Responses J. Virol., February 15, 2005; 79(4): 2230 - 2239. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, T. Zhang, C. Ho, J. S. Orange, S. D. Douglas, and W.-Z. Ho Natural killer cells inhibit hepatitis C virus expression J. Leukoc. Biol., December 1, 2004; 76(6): 1171 - 1179. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Eisen-Vandervelde, S. N. Waggoner, Z. Q. Yao, E. M. Cale, C. S. Hahn, and Y. S. Hahn Hepatitis C Virus Core Selectively Suppresses Interleukin-12 Synthesis in Human Macrophages by Interfering with AP-1 Activation J. Biol. Chem., October 15, 2004; 279(42): 43479 - 43486. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Q. Yao, A. Eisen-Vandervelde, S. N. Waggoner, E. M. Cale, and Y. S. Hahn Direct Binding of Hepatitis C Virus Core to gC1qR on CD4+ and CD8+ T Cells Leads to Impaired Activation of Lck and Akt J. Virol., June 15, 2004; 78(12): 6409 - 6419. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Maillard, J.-P. Lavergne, S. Siberil, G. Faure, F. Roohvand, S. Petres, J. L. Teillaud, and A. Budkowska Fc{gamma} Receptor-like Activity of Hepatitis C Virus Core Protein J. Biol. Chem., January 23, 2004; 279(4): 2430 - 2437. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-W. Youn, S.-H. Park, J. H. Cho, and Y. C. Sung Optimal Induction of T-Cell Responses against Hepatitis C Virus E2 by Antigen Engineering in DNA Immunization J. Virol., November 1, 2003; 77(21): 11596 - 11602. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sarobe, J. J. Lasarte, A. Zabaleta, L. Arribillaga, A. Arina, I. Melero, F. Borras-Cuesta, and J. Prieto Hepatitis C Virus Structural Proteins Impair Dendritic Cell Maturation and Inhibit In Vivo Induction of Cellular Immune Responses J. Virol., October 15, 2003; 77(20): 10862 - 10871. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Herzer, C. S. Falk, J. Encke, S. T. Eichhorst, A. Ulsenheimer, B. Seliger, and P. H. Krammer Upregulation of Major Histocompatibility Complex Class I on Liver Cells by Hepatitis C Virus Core Protein via p53 and TAP1 Impairs Natural Killer Cell Cytotoxicity J. Virol., August 1, 2003; 77(15): 8299 - 8309. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bergqvist, S. Sundstrom, L. Y. Dimberg, E. Gylfe, and M. G. Masucci The Hepatitis C Virus Core Protein Modulates T Cell Responses by Inducing Spontaneous and Altering T-cell Receptor-triggered Ca2+ Oscillations J. Biol. Chem., May 23, 2003; 278(21): 18877 - 18883. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Ning, S. Lakatoo, M. Liu, W. Yang, Z. Wang, M. J. Phillips, and G. A. Levy Induction of Prothrombinase fgl2 by the Nucleocapsid Protein of Virulent Mouse Hepatitis Virus Is Dependent on Host Hepatic Nuclear Factor-4alpha J. Biol. Chem., April 25, 2003; 278(18): 15541 - 15549. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ni, E. Hembrador, A. M. Di Bisceglie, I. M. Jacobson, A. H. Talal, D. Butera, C. M. Rice, T. J. Chambers, and L. B. Dustin Accumulation of B Lymphocytes with a Naive, Resting Phenotype in a Subset of Hepatitis C Patients J. Immunol., March 15, 2003; 170(6): 3429 - 3439. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wedemeyer, X.-S. He, M. Nascimbeni, A. R. Davis, H. B. Greenberg, J. H. Hoofnagle, T. J. Liang, H. Alter, and B. Rehermann Impaired Effector Function of Hepatitis C Virus-Specific CD8+ T Cells in Chronic Hepatitis C Virus Infection J. Immunol., September 15, 2002; 169(6): 3447 - 3458. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mahalingam, J. Meanger, P. S. Foster, and B. A. Lidbury The viral manipulation of the host cellular and immune environments to enhance propagation and survival: a focus on RNA viruses J. Leukoc. Biol., September 1, 2002; 72(3): 429 - 439. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Soguero, M. Joo, K. A. Chianese-Bullock, D. T. Nguyen, K. Tung, and Y. S. Hahn Hepatitis C Virus Core Protein Leads to Immune Suppression and Liver Damage in a Transgenic Murine Model J. Virol., August 12, 2002; 76(18): 9345 - 9354. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bichr, R. Rende-Fournier, G. Vona, A.-M. Yamamoto, E. Depla, G. Maertens, and C. Brechot Detection of neutralizing antibodies to hepatitis C virus using a biliary cell infection model J. Gen. Virol., June 1, 2002; 83(7): 1673 - 1678. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Varaklioti, N. Vassilaki, U. Georgopoulou, and P. Mavromara Alternate Translation Occurs within the Core Coding Region of the Hepatitis C Viral Genome J. Biol. Chem., May 10, 2002; 277(20): 17713 - 17721. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sarobe, J. J. Lasarte, N. Casares, A. Lopez-Diaz de Cerio, E. Baixeras, P. Labarga, N. Garcia, F. Borras-Cuesta, and J. Prieto Abnormal Priming of CD4+ T Cells by Dendritic Cells Expressing Hepatitis C Virus Core and E1 Proteins J. Virol., April 16, 2002; 76(10): 5062 - 5070. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-X. Liu, H. Nishida, J.-W. He, M. M. C. Lai, N. Feng, and G. Dennert Hepatitis C Virus Genotype 1b Core Protein Does Not Exert Immunomodulatory Effects on Virus-Induced Cellular Immunity J. Virol., February 1, 2002; 76(3): 990 - 997. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. PERLEMUTER, A. SABILE, P. LETTERON, G. VONA, A. TOPILCO, Y. CHRETIEN, K. KOIKE, D. PESSAYRE, J. CHAPMAN, G. BARBA, et al. Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral-related steatosis FASEB J, February 1, 2002; 16(2): 185 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-T. K. Tseng and G. R. Klimpel Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions J. Exp. Med., December 31, 2001; 195(1): 43 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sun, F. Bodola, X. Fan, H. Irshad, L. Soong, S. M. Lemon, and T.-S. Chan Hepatitis C Virus Core and Envelope Proteins Do Not Suppress the Host's Ability To Clear a Hepatic Viral Infection J. Virol., December 15, 2001; 75(24): 11992 - 11998. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Q. Yao, D. T. Nguyen, A. I. Hiotellis, and Y. S. Hahn Hepatitis C Virus Core Protein Inhibits Human T Lymphocyte Responses by a Complement-Dependent Regulatory Pathway J. Immunol., November 1, 2001; 167(9): 5264 - 5272. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Maillard, K. Krawczynski, J. Nitkiewicz, C. Bronnert, M. Sidorkiewicz, P. Gounon, J. Dubuisson, G. Faure, R. Crainic, and A. Budkowska Nonenveloped Nucleocapsids of Hepatitis C Virus in the Serum of Infected Patients J. Virol., September 1, 2001; 75(17): 8240 - 8250. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schweizer and E. Peterhans Noncytopathic Bovine Viral Diarrhea Virus Inhibits Double-Stranded RNA-Induced Apoptosis and Interferon Synthesis J. Virol., May 15, 2001; 75(10): 4692 - 4698. [Abstract] [Full Text] |
||||
![]() |
A. Bergqvist and C. M. Rice Transcriptional Activation of the Interleukin-2 Promoter by Hepatitis C Virus Core Protein J. Virol., January 15, 2001; 75(2): 772 - 781. [Abstract] [Full Text] |
||||
![]() |
T.-H. Wang, R. C. A. Rijnbrand, and S. M. Lemon Core Protein-Coding Sequence, but Not Core Protein, Modulates the Efficiency of Cap-Independent Translation Directed by the Internal Ribosome Entry Site of Hepatitis C Virus J. Virol., December 1, 2000; 74(23): 11347 - 11358. [Abstract] [Full Text] |
||||
![]() |
J. Matsumoto, S. Kawai, K. Terao, M. Kirinoki, Y. Yasutomi, M. Aikawa, and H. Matsuda Malaria Infection Induces Rapid Elevation of the Soluble Fas Ligand Level in Serum and Subsequent T Lymphocytopenia: Possible Factors Responsible for the Differences in Susceptibility of Two Species of Macaca Monkeys to Plasmodium coatneyi Infection Infect. Immun., March 1, 2000; 68(3): 1183 - 1188. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Liang, B. Rehermann, L. B. Seeff, and J. H. Hoofnagle Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C Ann Intern Med, February 15, 2000; 132(4): 296 - 305. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Arichi, T. Saito, M. E. Major, I. M. Belyakov, M. Shirai, V. H. Engelhard, S. M. Feinstone, and J. A. Berzofsky Prophylactic DNA vaccine for hepatitis C virus (HCV) infection: HCV-specific cytotoxic T lymphocyte induction and protection from HCV-recombinant vaccinia infection in an HLA-A2.1 transgenic mouse model PNAS, January 4, 2000; 97(1): 297 - 302. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shimoike, S. Mimori, H. Tani, Y. Matsuura, and T. Miyamura Interaction of Hepatitis C Virus Core Protein with Viral Sense RNA and Suppression of Its Translation J. Virol., December 1, 1999; 73(12): 9718 - 9725. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |